The Role of Botulinum Toxin Type A in the Radiation Fibrosis Syndrome: A Preliminary Report

Abstract Stubblefield MD, Levine A, Custodio CM, Fitzpatrick T. The role of botulinum toxin type A in the radiation fibrosis syndrome: a preliminary report. Objective To describe the use of botulinum toxin type A (BTX-A) in radiation fibrosis syndrome (RFS). Design Retrospective case series. Setting...

Full description

Saved in:
Bibliographic Details
Published in:Archives of physical medicine and rehabilitation Vol. 89; no. 3; pp. 417 - 421
Main Authors: Stubblefield, Michael D., MD, Levine, Aaron, MD, Custodio, Christian M., MD, Fitzpatrick, Theresa, PT
Format: Journal Article
Language:English
Published: New York, NY Elsevier Inc 01-03-2008
Elsevier
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Stubblefield MD, Levine A, Custodio CM, Fitzpatrick T. The role of botulinum toxin type A in the radiation fibrosis syndrome: a preliminary report. Objective To describe the use of botulinum toxin type A (BTX-A) in radiation fibrosis syndrome (RFS). Design Retrospective case series. Setting A large tertiary care cancer center. Participants Twenty-three consecutive patients treated for sequelae of RFS with BTX-A. Interventions Not applicable. Main Outcome Measures A description of the components of RFS thought to benefit from BTX-A injections and the patient’s self-report of benefit from those injections. Results The sequelae of RFS for which BTX-A injection was thought to be indicated include radiation-induced cervical dystonia in 18 (78%), trigeminal nerve or cervical plexus neuralgia in 10 (43%), trismus in 7 (30%), migraine in 3 (13%), and thoracic pain in 1 (4%) patient. Most (87%) patients self-reported benefit from the injections. Conclusions Initial clinical experience with the use of BTX-A as adjunctive treatment for select neuromuscular and musculoskeletal complications of RFS in a variety of cancer patients has been encouraging. Well-designed prospective studies are needed to clarify the potential beneficial role of BTX-A in specific sequelae of RFS.
ISSN:0003-9993
1532-821X
DOI:10.1016/j.apmr.2007.11.022